Clinical Trials Browser

Withdrawn × Neoadjuvant Therapy × Clear all

NCT07475923 2026-04-16

Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)

Breast Neoplasms

NCT05574712 2024-03-18

A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT03135652 2024-01-03

Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT03121989 2023-03-30

LABC

Phase 1 Withdrawn

Breast Neoplasms

NCT04849377 2022-07-07

RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC

Phase 2 Withdrawn

Squamous Cell Carcinoma of Head and Neck

NCT00397761 2021-02-17

Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 2/3 Withdrawn

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT03323424 2020-01-30

IRAM

Phase 2 Withdrawn

BreastGastrointestinalHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT02584556 2019-06-04

Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma

Phase 2/3 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

NCT01233479 2019-04-01

Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy

Phase NA Withdrawn

Central Nervous System Neoplasms, Rhabdoid Tumor

NCT00408772 2017-06-09

Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00635245 2015-03-11

CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery

Phase 1 Withdrawn

Breast Neoplasms

NCT00084578 2013-07-15

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Phase NA Withdrawn

Urinary Bladder Neoplasms

NCT00080613 2013-07-10

Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms

NCT00268255 2013-04-16

Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer

Phase 1/2 Withdrawn

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT00960427 2013-04-16

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

Phase 1 Withdrawn

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT00524069 2013-02-01

Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

Phase NA Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT00244920 2012-05-28

Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT00696007 2012-02-17

Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer

Phase 2 Withdrawn

Carcinoma, Transitional Cell